• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Regression of hypertension : molecular analysis and epigenetic assessment

Research Project

Project/Area Number 20590984
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Kidney internal medicine
Research InstitutionKeio University

Principal Investigator

SASAMURA Hiroyuki  Keio University, 医学部, 准教授 (00235293)

Co-Investigator(Kenkyū-buntansha) ITOH Hiroshi  慶應義塾大学, 医学部, 教授 (40252457)
Project Period (FY) 2008 – 2010
Project Status Completed (Fiscal Year 2010)
Budget Amount *help
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2010: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2009: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2008: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Keywords高血圧 / 退行 / レニンーアンジオテンシン系 / 糸球体硬化
Research Abstract

Hypertension is the most prevalent disease in Japan, and affects at least one in four of the general population. Although hypertension is considered to be a progressive, irreversible disease, we demonstrated in this study that reversal or regression of hypertension may be feasible in animal models of hypertension. Regression of hypertension was achieved by 'pulse' treatment with an angiotensin receptor blocker at 10-50 times the normal dose, by a mechanism involving reversal of renal arteriolar hypertrophy.

Report

(4 results)
  • 2010 Annual Research Report   Final Research Report ( PDF )
  • 2009 Annual Research Report
  • 2008 Annual Research Report
  • Research Products

    (38 results)

All 2010 2009 2008

All Journal Article (12 results) (of which Peer Reviewed: 12 results) Presentation (26 results)

  • [Journal Article] Regression of glomerulosclerosis in response to transient treatment with angiotensin II blockers is attenuated by blockade of matrix metalloproteinase-2.2010

    • Author(s)
      K.Hayashi, H.Sasamura, K.Ishiguro, Y.Sakamaki, T.Azegami, H.Itoh
    • Journal Title

      Kidney International 78

      Pages: 69-78

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Absence of gelatinase (MMP-9) or collagenase (MMP-13) attenuates adriamycin-induced albuminuria and glomerulosclerosis.2010

    • Author(s)
      Y.Sakamaki, H.Sasamura, K.Hayashi, K.Ishiguro, H.Takaishi, H.Okada, J.M.D'Armiento, T.Saruta, H.Itoh
    • Journal Title

      Nephron 115

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Regression of glomerulosclerosis in response to transient treatment with angiotensin II blockers is attenuated by blockade of matrix metalloproteinase-2.2010

    • Author(s)
      K.Hayashi, H.Sasamura, et al.
    • Journal Title

      Kidney International

      Volume: 78 Pages: 69-78

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Absence of gelatinase (MMP-9) or collagenase (MMP-13) attenuates adriamycin-induced albuminuria and glomerulosclerosis.2010

    • Author(s)
      Y.Sakamaki, H.Sasamura, et al.
    • Journal Title

      Nephron

      Volume: 115 Pages: 22-32

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Pulse treatment with high-dose angiotensin blocker reverses renal arteriolar hypertrophy and regresses hypertension.2009

    • Author(s)
      K.Ishiguro, K.Hayashi, H.Sasamura, Y.Sakamaki, H.Itoh
    • Journal Title

      Hypertension 53

      Pages: 83-89

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Prevention and regression of hypertension: role of renal microvascular protection.2009

    • Author(s)
      H.Sasamura, K.Hayashi, K.Ishiguro, H.Nakaya, T.Saruta, H.Itoh
    • Journal Title

      Hypertension Research 32

      Pages: 658-664

    • NAID

      10025164652

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] 'Pulse' treatment with high-dose angiotensin blocker reverses renal arteriolar hypertrophy and regresses hypertension2009

    • Author(s)
      K.Ishiguro, H.Sasamura, et al.
    • Journal Title

      Hypertension 53

      Pages: 83-89

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Prevention and regression of hypertension : role of renal microvascular protection2009

    • Author(s)
      H.Sasamura, K.Hayashi, et al.
    • Journal Title

      Hypertension Research 32

      Pages: 658-664

    • NAID

      10025164652

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Differential effects of transient treatment of spontaneously hypertensive rats with various antihypertensive agents on the subsequent development of diabetic nephropathy.2008

    • Author(s)
      K.Ishiguro, H.Sasamura, Y.Sakamaki, K.Hayashi, H.Itoh
    • Journal Title

      Nephron 109

      Pages: 20-28

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Short treatment with the angiotensin receptor blocker candesartan surveyed by telemedicine (STAR CAST) study : rationale and study design.2008

    • Author(s)
      H.Sasamura, H.Nakaya, T.Takebayashi, Y.Sato, K.Ishiguro, M.Ryuzaki, M.Murakami, S.Julius, H.Itoh
    • Journal Title

      Hypertension Research 31

      Pages: 1843-1849

    • NAID

      10024827357

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Differential effects of transient treatment of spontaneously hyperten sive rats with various antihypertensive agents on the subsequent de velopment of diabetic nephropathy2008

    • Author(s)
      K. Ishiguro, H, Sasamura, et al.
    • Journal Title

      Nephron 109

      Pages: 20-28

    • Related Report
      2008 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Short treatment with the angiotensin receptor blocker candesartan surveyed by telemedicine (STAR CAST) study : rationale and studydesign2008

    • Author(s)
      H. Sasamura, H. Nakaya, et al.
    • Journal Title

      Hypertension Research 31

      Pages: 1843-1849

    • Related Report
      2008 Annual Research Report
    • Peer Reviewed
  • [Presentation] Transient treatment with high-dose angiotensin receptor blocker (ARB) causes regression of hypertension in a rat model of metabolic syndrome (SHRmcr-cp).2010

    • Author(s)
      K.Ishiguro, H.Sasamura, et al.
    • Organizer
      23rd International Society of Hypertension
    • Place of Presentation
      Vancouver
    • Year and Date
      2010-09-28
    • Related Report
      2010 Annual Research Report
  • [Presentation] Short-term treatment with high-dose angiotensin blocker (ARB) induces sustained regression of adriamycin-induced glomerulosclerosis and albuminuria.2010

    • Author(s)
      K.Hayashi, H.Sasamura, et al.
    • Organizer
      23rd International Society of Hypertension
    • Place of Presentation
      Vancouver
    • Year and Date
      2010-09-28
    • Related Report
      2010 Annual Research Report
  • [Presentation] The short treatment with the angiotensin receptor blocker candesartan surveyed by telemedicine (STAR CAST) study : design and preliminary report.2010

    • Author(s)
      H.Sasamura, H.Nakaya, S.Julius, Y.Sato, H.Itoh
    • Organizer
      23^<rd> Scientific Meeting of the International Society of Hypertension
    • Place of Presentation
      Vancouver
    • Year and Date
      2010-09-26
    • Related Report
      2010 Final Research Report
  • [Presentation] Transient treatment with high-dose angiotensin receptor blocker (ARB) causes regression of hypertension in a rat model of metabolic syndrome (SHRmcr-cp).2010

    • Author(s)
      K.Ishiguro, H.Sasamura, Y.Sakamaki, K.Hayashi, T Azegami, H.Itoh
    • Organizer
      23^<rd> Scientific Meeting of the International Society of Hypertension
    • Place of Presentation
      Vancouver
    • Year and Date
      2010-09-26
    • Related Report
      2010 Final Research Report
  • [Presentation] Prevention of hypertension and renal injury by a renin-angiotensin system (RAS) vaccine in L-NAME-treated spontaneously hypertensive rats (SHR).2010

    • Author(s)
      T.Azegami, H.Sasamura, K.Hayashi, K.Ishiguro, H.Itoh
    • Organizer
      23^<rd> Scientific Meeting of the International Society of Hypertension
    • Place of Presentation
      Vancouver
    • Year and Date
      2010-09-26
    • Related Report
      2010 Final Research Report
  • [Presentation] Short-term treatment with high-dose angiotensin blocker (ARB) induces sustained regression of adriamycin-induced glomerulosclerosis and albuminuria.2010

    • Author(s)
      K.Hayashi, H.Sasamura, K.Ishiguro, Y.Sakamaki, T.Azegami, H.Itoh
    • Organizer
      23^<rd> Scientific Meeting of the International Society of Hypertension
    • Place of Presentation
      Vancouver
    • Year and Date
      2010-09-26
    • Related Report
      2010 Final Research Report
  • [Presentation] Assessment of potential risk factors for cardiovascular disease in patients with chronic kidney disease (CKD) by metabolome analysis.2010

    • Author(s)
      K.Hayashi, H.Sasamura, T.Hishiki, M.Suematsu, S.Ikeda, T.Soga, H.Itoh
    • Organizer
      23^<rd> Scientific Meeting of the International Society of Hypertension
    • Place of Presentation
      Vancouver
    • Year and Date
      2010-09-26
    • Related Report
      2010 Final Research Report
  • [Presentation] Efficacy of renin-angiotensin system (RAS) vaccine for prevention of proteinuria and renal injury in spontaneously hypertensive rats (SHR).2010

    • Author(s)
      T.Azegami, H.Sasamura, K.Hayashi, K.Ishiguro, H.Itoh
    • Organizer
      6^<th> International Congress of Pathophysiology
    • Place of Presentation
      Montreal
    • Year and Date
      2010-09-22
    • Related Report
      2010 Final Research Report
  • [Presentation] Role of extracellular matrix (ECM) remodeling in high-dose angiotensin blocker-induced regression of hypertension and glomerulosclerosis.2010

    • Author(s)
      K.Hayashi, H.Sasamura, K.Ishiguro, Y.Sakamaki, T.Azegami, H.Itoh
    • Organizer
      6^<th> International Congress of Pathophysiology
    • Place of Presentation
      Montreal
    • Year and Date
      2010-09-22
    • Related Report
      2010 Final Research Report
  • [Presentation] The short treatment with the angiotensin receptor blocker candesartan surveyed by telemedicine (STAR CAST) study : rationale and interim report.2010

    • Author(s)
      H.Sasamura, H.Nakaya, S.Julius, Y.Sato, H.Itoh
    • Organizer
      20^<th> European Meeting of Hypertension
    • Place of Presentation
      Oslo
    • Year and Date
      2010-06-18
    • Related Report
      2010 Final Research Report
  • [Presentation] Prevention of proteinuria and renal injury by a renin-angiotensin system (RAS) vaccine in spontaneously hypertensive rats (SHR).2010

    • Author(s)
      T.Azegami, H.Sasamura, K.Hayashi, K.Ishiguro, H.Itoh
    • Organizer
      International Society of Nephrology Nexus Symposium
    • Place of Presentation
      Kyoto
    • Year and Date
      2010-04-15
    • Related Report
      2010 Final Research Report
  • [Presentation] Treatment with high-dose angiotensin blocker regresses adriamycin-induced glomerulosclerosis and albuminuria.2010

    • Author(s)
      K.Hayashi, H.Sasamura, K.Ishiguro, Y.Sakamaki, T.Azegami, H.Itoh
    • Organizer
      International Society of Nephrology Nexus Symposium
    • Place of Presentation
      Kyoto
    • Year and Date
      2010-04-15
    • Related Report
      2010 Final Research Report
  • [Presentation] Metabolomic profiling as a tool for the assessment of patients with chronic kidney disease.2010

    • Author(s)
      K.Hayashi, H.Sasamura, T.Hishiki, M.Suematsu, S.Ikeda, T.Soga, H.Itoh
    • Organizer
      International Society of Nephrology Nexus Symposium
    • Place of Presentation
      Kyoto
    • Year and Date
      2010-04-15
    • Related Report
      2010 Final Research Report
  • [Presentation] Microarray analysis of mechanisms involved in the prevention and regression of hypertension by angiotensin receptor blocker (ARB) in spontaneously hypertensive rats.2010

    • Author(s)
      H.Sasamura, K.Hayashi, K.Ishiguro, Y.Sakamaki, T.Azegami, H.Itoh
    • Organizer
      14^<th> International Congress of Endocrinology
    • Place of Presentation
      Kyoto
    • Year and Date
      2010-03-26
    • Related Report
      2010 Final Research Report
  • [Presentation] 'Pulse' treatment with high-dose angiotensin receptor blocker (ARB) causes regression of hypertension in SHRmcr-cp rats with metabolic syndrome.2010

    • Author(s)
      K.Ishiguro, H.Sasamura, Y.Sakamaki, K.Hayashi, H.Itoh
    • Organizer
      14^<th> International Congress of Endocrinology
    • Place of Presentation
      Kyoto
    • Year and Date
      2010-03-26
    • Related Report
      2010 Final Research Report
  • [Presentation] メタボリックシンドローム(MetS)モデル動物に対する「ARB高用量パルス投与」の効果の検討2009

    • Author(s)
      石黒喜美子、篠村裕之, 他
    • Organizer
      第32回日本高血圧学会総会
    • Place of Presentation
      大津
    • Year and Date
      2009-10-01
    • Related Report
      2009 Annual Research Report
  • [Presentation] ARB高用量一過性投与は高血圧モデル動物において高血圧の退行(regression)と心血管肥大の抑制をもたらず2009

    • Author(s)
      石黒喜美子、篠村裕之, 他
    • Organizer
      第45回高血圧関連疾患モデル学会
    • Place of Presentation
      東京
    • Year and Date
      2009-09-05
    • Related Report
      2009 Annual Research Report
  • [Presentation] Transient prepubertal exposure to an ARB or aldosterone antagonist suppresses the subsequent development of diabetic nephropathy2008

    • Author(s)
      K. Ishiguro, H. Sasamura, et al.
    • Organizer
      22^n International Society of Hypertension
    • Place of Presentation
      Berlin
    • Year and Date
      2008-06-21
    • Related Report
      2008 Annual Research Report
  • [Presentation] Short treatment with the angiotensin receptor blocker candesartan surveyed by telemedicine (STAR CAST) study : rationale and study design2008

    • Author(s)
      H. Sasamura, H. Nakaya, et al.
    • Organizer
      22^n International Society of Hypertension
    • Place of Presentation
      Berlin
    • Year and Date
      2008-06-21
    • Related Report
      2008 Annual Research Report
  • [Presentation] Matrix metalloproteinase-9 (MMP-9) deletion suppresses the development of glomerulosclerosis in mice by a blood pressureand oxidative stress-independent mechanism.2008

    • Author(s)
      Y.Sakamaki, H.Sasamura, K.Kshiguro, K.Hayashi, Y.Okada, T.Saruta, H.Itoh
    • Organizer
      22nd Scientific Meeting, International Society of Hypertension
    • Place of Presentation
      Berlin
    • Year and Date
      2008-06-14
    • Related Report
      2010 Final Research Report
  • [Presentation] Comparison of costs between angiotensin receptor blocker (ARB) and calcium channel blocker (CCB) in hypertensive patients with high cardiovascular risks and analysis of the effects of new-onset diabetes, from the CASE-J Trial.2008

    • Author(s)
      H.Nakaya, H.Sasamura, Y.Sakamaki, S.Ikeda, Y.Sato, H.Itoh
    • Organizer
      22nd Scientific Meeting, International Society of Hypertension
    • Place of Presentation
      Berlin
    • Year and Date
      2008-06-14
    • Related Report
      2010 Final Research Report
  • [Presentation] Transient prepubertal exposure to an angiotensin receptor blocker or aldosterone antagonist suppresses the development of nephropathy in streptozotocin-induced diabetic hypertensive rats.2008

    • Author(s)
      K.Ishiguro, H.Sasamura, Y.Sakamaki, K.Hayashi, T.Saruta, H.Itoh
    • Organizer
      22nd Scientific Meeting, International Society of Hypertension
    • Place of Presentation
      Berlin
    • Year and Date
      2008-06-14
    • Related Report
      2010 Final Research Report
  • [Presentation] 'Pulse' treatment with high-dose angiotensin receptor blocker (ARB) causes prominent regression of established glomerulosclerotic lesions in mice.2008

    • Author(s)
      K.Hayashi, H.Sasamura, K.Ishiguro, Y.Sakamaki, H.Itoh
    • Organizer
      22nd Scientific Meeting, International Society of Hypertension
    • Place of Presentation
      Berlin
    • Year and Date
      2008-06-14
    • Related Report
      2010 Final Research Report
  • [Presentation] Microarray analysis of vascular and renal mechanisms involved in suppression of hypertension development by prehypertensive treatment in spontaneously hypertensive rats (SHR).2008

    • Author(s)
      K.Hayashi, K.Ishiguro, H.Sasamura, Y.Sakamaki, H.Itoh
    • Organizer
      22nd Scientific Meeting, International Society of Hypertension
    • Place of Presentation
      Berlin
    • Year and Date
      2008-06-14
    • Related Report
      2010 Final Research Report
  • [Presentation] Effects of 'pulse' treatment with high-dose angiotensin receptor blocker (ARB) or calcium channel blocker (CCB) on regression of hypertension and microvascular remodeling in spontaneously hypertensive rats (SHR).2008

    • Author(s)
      K.Ishiguro, K.Hayashi, H.Sasamura, Y.Sakamaki, T.Saruta, H.Itoh
    • Organizer
      22nd Scientific Meeting, International Society of Hypertension
    • Place of Presentation
      Berlin
    • Year and Date
      2008-06-14
    • Related Report
      2010 Final Research Report
  • [Presentation] Short treatment with the angiotensin receptor blocker candesartan surveyed by telemedicine (STAR CAST) study : rationale and study design.2008

    • Author(s)
      H.Sasamura, H.Nakaya, T.Takebayashi, Y.Sato, K.Ishiguro, M.Ryuzaki, M.Murakami, S.Julius, H.Itoh
    • Organizer
      22nd Scientific Meeting, International Society of Hypertension
    • Place of Presentation
      Berlin
    • Year and Date
      2008-06-14
    • Related Report
      2010 Final Research Report

URL: 

Published: 2008-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi